Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Vorinostat in Treating Patients With Metastatic Melanoma of the Eye

This study has suspended participant recruitment.
(Non-compliance with Sponsor data reporting requirements)
Sponsor:
Collaborators:
Institut Curie Paris
Memorial Sloan Kettering Cancer Center
Moffitt Cancer Center P2C
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01587352
First received: April 26, 2012
Last updated: March 23, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Study Completion Date: No date given
  Estimated Primary Completion Date: November 2017 (Final data collection date for primary outcome measure)